Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years).
Cancer Biomark
; 30(1): 95-104, 2021.
Article
in En
| MEDLINE
| ID: mdl-32986661
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Tumor Suppressor Protein p53
/
Proto-Oncogene Proteins c-bcl-2
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Cancer Biomark
Journal subject:
BIOQUIMICA
/
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: